Yorktown Management & Research CO Inc Merck & Co., Inc. Transaction History

Yorktown Management & Research CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $301,434 - $334,530	-4,200 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $295,764 - $336,546	4,200 New	4,200 $325,000
Q2 2019 Aug 02, 2019	SELL	$69.84 - $81.59 $1.26 Million - $1.47 Million	-18,000 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $358,820 - $416,404	-5,500 Reduced 23.4%	18,000 $1.38 Million
Q3 2018 Nov 08, 2018	BUY	$57.69 - $67.84 $403,830 - $474,880	7,000 Added 42.42%	23,500 $1.67 Million
Q1 2018 May 11, 2018	BUY	$50.96 - $59.23 $50,960 - $59,230	1,000 Added 6.45%	16,500 $899,000
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $567,820 - $678,040	11,000 Added 244.44%	15,500 $872,000
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $264,015 - $284,085	4,500	4,500 $288,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.